相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Infant Dextromethorphan and Dextrorphan Exposure via Breast Milk From Mothers Who Are CYP2D6 Extensive Metabolizers
Sara Shum et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic
Aprajita S. Yadav et al.
DRUG METABOLISM AND DISPOSITION (2022)
Plasma Retinoid Concentrations Are Altered in Pregnant Women
Lindsay C. Czuba et al.
NUTRIENTS (2022)
The use of isotretinoin for acne - an update on optimal dosing, surveillance, and adverse effects
Edileia Bagatin et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2020)
A Review of the Important Role of CYP2D6 in Pharmacogenomics
Christopher Taylor et al.
GENES (2020)
Determinants of Cytochrome P450 2D6 mRNA Levels in Healthy Human Liver Tissue
Miaoran Ning et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)
Does In Vitro Cytochrome P450 Downregulation Translate to In Vivo Drug-Drug Interactions? Preclinical and Clinical Studies With 13-cis-Retinoic Acid
Faith Stevison et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)
Tacrolimus Population Pharmacokinetics and Multiple CYP3A5 Genotypes in Black and White Renal Transplant Recipients
Olivia Campagne et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Frequency of CYP2D6 Alleles Including Structural Variants in the United States
Andria L. Del Tredici et al.
FRONTIERS IN PHARMACOLOGY (2018)
Ten Years' Experience with the CYP2D6 Activity Score: A Perspective on Future Investigations to Improve Clinical Predictions for Precision Therapeutics
Andrea Gaedigk et al.
JOURNAL OF PERSONALIZED MEDICINE (2018)
The inhibition of UDP-glucuronosyltransferases (UGTs) by vitamin A
Xin Liu et al.
XENOBIOTICA (2017)
Cholic Acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice
Xian Pan et al.
DRUG METABOLISM AND DISPOSITION (2017)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing
K. A. Birdwell et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Estrogen-Induced Cholestasis Leads to Repressed CYP2D6 Expression in CYP2D6-Humanized Mice
Xian Pan et al.
MOLECULAR PHARMACOLOGY (2015)
Altered Expression of Small Heterodimer Partner Governs Cytochrome P450 (CYP) 2D6 Induction during Pregnancy in CYP2D6-humanized Mice
Kwi Hye Koh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants
J. K. Hicks et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Hepatic Cyp2d and Cyp26a1 mRNAs and Activities Are Increased During Mouse Pregnancy
Ariel R. Topletz et al.
DRUG METABOLISM AND DISPOSITION (2013)
A sensitive and specific method for measurement of multiple retinoids in human serum with UHPLC-MS/MS
Samuel L. M. Arnold et al.
JOURNAL OF LIPID RESEARCH (2012)
Prediction of Relative In Vivo Metabolite Exposure from In Vitro Data Using Two Model Drugs: Dextromethorphan and Omeprazole
Justin D. Lutz et al.
DRUG METABOLISM AND DISPOSITION (2012)
Retinoids activate RXR/CAR-mediated pathway and induce CYP3A
Shiyong Chen et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver
Xia Yang et al.
GENOME RESEARCH (2010)
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
Magnus Ingelman-Sundberg et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17
Hongwu Shen et al.
DRUG METABOLISM AND DISPOSITION (2007)
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity
M Ingelman-Sundberg
PHARMACOGENOMICS JOURNAL (2005)
CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants
LD Bradford
PHARMACOGENOMICS (2002)
The CYP2D6 humanized mouse:: Effect of the human CYP2D6 transgene and HNF4α on the disposition of debrisoquine in the mouse
J Corchero et al.
MOLECULAR PHARMACOLOGY (2001)
Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity
C Rodríguez-Antona et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2001)
Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan
JS McCune et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp
LA Denson et al.
GASTROENTEROLOGY (2001)
Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes:: A study using adenovirus-mediated antisense targeting
R Jover et al.
HEPATOLOGY (2001)
Quantitative RT-PCR measurement of human cytochrome P-450s:: Application to drug induction studies
C Rodríguez-Antona et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
4-Hydroxyretinoic acid, a novel substrate for human liver microsomal UDP-glucuronosyltransferase(s) and recombinant UGT2B7
VM Samokyszyn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
